Company intelligence / Profile preview

KyooBe Tech GmbH

Leinfelden-Echterdingen, Baden-Württemberg, Germanykyoobe.tech ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

KyooBe Tech develops advanced automation solutions to improve pharmaceutical manufacturing processes with a focus on vaccines and cell/gene therapies. Their flagship products include modular platforms like INACTIVATE and MOSAIC that enable efficient pathogen inactivation and scalable personalized medicine production. The company leverages interdisciplinary expertise to accelerate process transfer within biotech manufacturing but does not develop its own therapeutic drugs or biologics.

Therapeutic areas: Other
Modalities: Cell therapiesVaccinesPathogen inactivation devices using low energy electron irradiation
Industry: Non-Drug Biotech

Partnerships

Bausch+Ströbel SE + Co. KG (strategic partner)

Beyond the preview

Go deeper on KyooBe Tech GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KyooBe Tech GmbH.

Explore the full profile